IPP Bureau
Alithea Genomics and Revvity expand global access to scalable transcriptomics platforms
By IPP Bureau - June 16, 2026
Collaboration integrates MERCURIUS DRUG-seq technologies with Revvity’s screening portfolio, enabling scalable transcriptomic profiling for next-generation drug discovery and AI-driven research
Lumos Health opens applications for second cohort of HealthTech and MedTech startups
By IPP Bureau - June 16, 2026
Healthcare speed-scaling platform offers clinical validation, regulatory support, mentorship, and investor access to startups working across preventive health, oncology, genomics, diagnostics, and digital health
India’s bioeconomy grew 20-fold in last 12 years: Dr Jitendra Singh
By IPP Bureau - June 16, 2026
From a $10 billion bioeconomy to over $190 billion, indigenous CAR-T therapy, and a booming startup ecosystem highlight 12 years of transformation in India’s science and technology landscape
FDA clears Dexcom’s Stelo as first OTC Continuous Glucose Monitor for kids
By IPP Bureau - June 16, 2026
Expanded indication makes Stelo the first FDA-cleared OTC CGM for children aged two years and older with diabetes or prediabetes
Lilly’s Jaypirca cuts risk of disease progression or death by 45% in landmark trial
By IPP Bureau - June 16, 2026
The study enrolled 639 patients, nearly 80% of whom had previously received a covalent BTK inhibitor
Roche wins FDA approval for first PTEN-loss companion diagnostic in prostate cancer
By IPP Bureau - June 16, 2026
The FDA nod marks a step forward in precision oncology, linking molecular diagnostics more tightly to therapy selection for advanced prostate cancer
OM Pharma to unveil major real-world evidence breakthrough on Broncho-Vaxom at EAACI
By IPP Bureau - June 16, 2026
The company will unveil preliminary findings showing that Broncho-Vaxom was associated with a 28–38% reduction in respiratory tract infection rates at 12 months
Siemens Healthineers begins manufacturing of Atellica chemistry reagents in India
By IPP Bureau - June 16, 2026
Production at Vadodara facility strengthens Make in India initiative, enhances access to diagnostic testing, and supports preventive healthcare across the country
Philips partners with Bajaj to build digitally connected healthcare network in India
By IPP Bureau - June 16, 2026
Collaboration to deploy Philips’ IntelliBridge Enterprise platform across Bajaj Integrated Health System network, enabling seamless patient data flow and integrated care delivery.
Yashoda Medicity, GE Healthcare strengthen partnership to expand AI-powered critical care
By IPP Bureau - June 16, 2026
Discussions focus on integrating ECG diagnostics into AI-enabled E-ICU Command Centre and expanding technology-driven healthcare access across underserved regions
Mabion reactivates MabionCD20 through rare disease collaboration with Oddifact
By IPP Bureau - June 16, 2026
MabionCD20 is a monoclonal antibody originally developed by Mabion as a biosimilar candidate to MabThera and Rituxan therapies
Cryoviva brings advanced PrepaCyte-CB cord blood processing technology to India
By IPP Bureau - June 16, 2026
Exclusive partnership introduces globally benchmarked stem cell processing platform aimed at improving stem cell recovery, quality, and long-term therapeutic potential
Granules India elevates Ananda Babu Doppalapudi as GM and Head Quality for Vizag API Unit
By IPP Bureau - June 16, 2026
Veteran quality professional with over 20 years of industry experience to lead quality operations at Unit-4 API manufacturing facility
T-CURX gets Swissmedic nod for first human trial of non-viral CAR-T therapy
By IPP Bureau - June 15, 2026
Phase 1 study to evaluate Siglec-6-targeted CAR-T therapy in relapsed or refractory AML and CLL patients, marking a major milestone for T-CURX’s scalable non-viral CAR-T platform
